Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 2, 2005
Chronic lymphocytic leukemia: a review of some new aspects of the biology, factors influencing prognosis and therapeutic optionsYair Herishanu, Aaron Polliack
Leukemia & Lymphoma|July 27, 2013
Therapeutic targeting of CD19 in hematological malignancies: past, present, future and beyondBen-Zion Katz, Yair Herishanu
British Journal of Haematology|April 12, 2023
Improved outcomes in patients with chronic lymphocytic leukaemia infected during the omicron BA.5 subvariant surgeYotam Bronstein, Shai Levi, Yair Herishanu
Anti-Cancer Drugs|March 20, 2002
The role of glucocorticoids in the treatment of fulminant hepatitis induced by dacarbazineYair Herishanu, Michael Lishner, Yona Kitay-Cohen
European Journal of Haematology|May 16, 2006
Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophiliaYair Herishanu, Ori Rogowski, Aaron Polliack, et al.
Hematology/Oncology Clinics of North America|April 9, 2013
Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implicationsYair Herishanu, Ben-Zion Katz, Andrew Lipsky, et al.
Leukemia & Lymphoma|February 13, 2004
Autoimmune thrombocytopenia in chronic myeloid leukemia treated with interferon-alpha: differential diagnosis and possible pathogenesisYair Herishanu, Svetlana Trestman, Ilya Kirgner, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 23, 2005
Venous and arterial thrombosis following administration of intravenous immunoglobulinsDaphna Paran, Yair Herishanu, Ori Elkayam, et al.
European Journal of Haematology|April 4, 2017
Familial chronic lymphocytic leukemia in Israel: A disproportionate distribution among Ashkenazi JewsMor Zada, Daniele Lerner, Yuval Piltz, et al.
Journal of Medical Virology|November 10, 2021
Evolution of spike mutations following antibody treatment in two immunocompromised patients with persistent COVID-19 infectionYotam Bronstein, Amos Adler, Haytham Katash, et al.
Pageof 11